Myriad Announces Coverage Decision by Kroger® Prescription Plans for GeneSight®

NEXT STORY
Corvus Pharmaceuticals to Provide Business Update and Report First Quarter 2019 Financial Results on May 9, 2019
PREV STORY
MacroGenics Provides Update on Corporate Progress and First Quarter 2019 Financial Results
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Roche’s COVID-19 antibody test receives FDA Emergency Use Authorization and is available in markets accepting the CE mark

author_avatar
NASDAQ Market News

Ascendis Pharma A/S Announces Third Quarter 2019 Financial Results and Business Update Conference Call on November 18

author_avatar
NASDAQ Market News

SELLAS Life Sciences to Host Virtual Investor Symposium on its Lead Asset, Galinpepimut-S, on August 17, 2021

author_avatar
NASDAQ Market News